Image
11.08.2025
86% of people with type 1 and 75% of people with type 2 experience jud...
Our new stigma research looks at diabetes stigma at scale across the UK. With blame, shame and stigma sta...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more